Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
出版年份 2021 全文链接
标题
Selection of endometrial carcinomas for
p53
immunohistochemistry based on nuclear features
作者
关键词
-
出版物
Journal of Pathology Clinical Research
Volume 8, Issue 1, Pages 19-32
出版商
Wiley
发表日期
2021-10-02
DOI
10.1002/cjp2.243
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
- (2021) Amy Jamieson et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
- (2021) Jessica N. McAlpine et al. CANCER
- Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
- (2021) Anna Merlotti et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer
- (2021) Sara Imboden et al. GYNECOLOGIC ONCOLOGY
- Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma
- (2020) Mary Anne Brett et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
- (2020) Eun Young Kang et al. MODERN PATHOLOGY
- Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features
- (2020) Amy Joehlin-Price et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- (2020) Nicole Concin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting
- (2020) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Interpretation of somatic POLE mutations in endometrial carcinoma
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas
- (2018) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Letter in response to: McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018; 244: 538-549
- (2018) Martin Köbel et al. JOURNAL OF PATHOLOGY
- The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
- (2018) Jessica McAlpine et al. JOURNAL OF PATHOLOGY
- Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies are Uncommon
- (2018) Nick Baniak et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- High-grade Endometrial Carcinomas
- (2018) Rajmohan Murali et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
- (2016) Mackenzie Coatham et al. MODERN PATHOLOGY
- Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases
- (2015) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
- (2015) Alon D. Altman et al. GYNECOLOGIC ONCOLOGY
- POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
- (2014) Bo Meng et al. GYNECOLOGIC ONCOLOGY
- Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
- (2014) Yaser R Hussein et al. MODERN PATHOLOGY
- Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas
- (2013) Lien N. Hoang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reproducibility of histological cell type in high-grade endometrial carcinoma
- (2013) Guangming Han et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started